Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) FCF Margin (2018 - 2025)

Lipocine (LPCN) has disclosed FCF Margin for 9 consecutive years, with 2605.93% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin changed N/A year-over-year to 2605.93%, compared with a TTM value of 119.12% through Sep 2025, down 5199.0%, and an annual FY2024 reading of 11.71%, up 40498.0% over the prior year.
  • FCF Margin was 2605.93% for Q3 2025 at Lipocine, down from 302.84% in the prior quarter.
  • Across five years, FCF Margin topped out at 5888.93% in Q1 2021 and bottomed at 12692.34% in Q3 2021.
  • Average FCF Margin over 5 years is 1255.02%, with a median of 193.16% recorded in 2025.
  • The sharpest move saw FCF Margin plummeted -472653bps in 2022, then surged 718210bps in 2024.
  • Year by year, FCF Margin stood at 55.92% in 2021, then tumbled by -1193bps to 611.33% in 2022, then surged by 202bps to 622.83% in 2023, then crashed by -92bps to 48.46% in 2024, then plummeted by -5478bps to 2605.93% in 2025.
  • Business Quant data shows FCF Margin for LPCN at 2605.93% in Q3 2025, 302.84% in Q2 2025, and 2097.99% in Q1 2025.